![](\"\/wp-content\/uploads\/2023\/09\/RPF-Indicadores-info1-site-1140.png\")
\n <\/picture>Spending on R&D is a measure of a country\u2019s efforts to stimulate development, and involves a set of activities conducted by companies, universities, and other scientific institutions, including basic and applied research results, new product launches, and training of researchers and qualified professionals. In current values (not deducting inflation), federal government R&D disbursements increased from R$29 billion in 2019 to R$32.7 billion in 2020, notably investments by the Ministries of Health (R$3 billion in 2020 against R$1.9 billion in 2019) and of Science, Technology, and Innovation (rising from R$5.3 billion to R$8.1 billion), who focused their spending on investigating and tackling COVID-19. However, there was decreased R&D spending across ministries such as Education (from R$17.9 billion to R$17.7 billion) and Agriculture (from R$3.8 billion to R$3.4 billion).<\/p>\n
Investments made by individual states remained steady: they reached a total of R$14.1 billion in current values in 2020, practically the same as 2019, a shortfall from the R$17 billion recorded for 2018. Certain states managed to increase their investments, such as Paran\u00e1 (from R$960 million to R$1.2 billion from one year to the next). Others lost momentum, such as Minas Gerais (a drop from R$293 million to R$248 million). S\u00e3o Paulo increased slightly, from R$9.1 billion to R$9.2 billion.<\/p>\n In absolute terms, scientific output grew in Brazil from 82,700 articles published in 2019 to 89,200 in 2020, and then 94,500 in 2021, according to data from the Scopus base, remaining in 13th<\/sup> place in the country rankings, with 2.7% of global yield. \u201cComparatively speaking, Brazil holds an intermediate position among the BRICS group [Brazil, Russia, India, China, and South Africa], with growth rates well below those of China and India, but exceeding those of Russia and South Africa,\u201d says Paiva, who evaluated, in a recent OCTI\/CGEE bulletin, Brazilian scientific output according to another database, Web of Science.<\/p>\n \u201cOur output has grown less than that of countries that opted for expressive funding of science. If we do not resume investments, the tendency is that we will get farther and farther behind,\u201d says Mariana Moura, director of the Department for Strategic Management and Indicators at the Ministry of Science, Technology, and Innovation (MCTI), responsible for annual compilation and dissemination of National Indicators. \u201cThe pandemic alone does not explain this downturn in the system \u2014 the reduction in investments over recent years is also cause for concern,\u201d she states, referring to the budget cuts and innovation funding restrictions occurring since the middle of the last decade.<\/p>\n The most evident impact of the pandemic appears in the statistics on postgraduation in Brazil, with a downturn in the number of doctorates awarded (from 24,400 in 2019 to just over 20,000 in 2020 and 2021), and a decline in master\u2019s degrees as well. Renato Pedrosa observes that this decline, as far as can be seen from the statistics, is not due to students avoiding postgraduate courses (see Data<\/em><\/a>). \u201cThe number of master\u2019s and doctorates awarded fell, but numbers of students enrolled on the corresponding courses increased in equal proportion, a sign that this may merely have been due to postponement of dissertation and thesis defenses due to the pandemic,\u201d he concludes.<\/p>\n Various indicators, even presenting fluctuations, suggest that the science and technology system in Brazil is resilient. In 2020 there were 27,100 patent applications in the country, a slight reduction against the four preceding years, but well below levels seen prior to the economic crisis of the last decade (33,000 applications were filed in 2015). Even the corporate investment reduction in R&D was repeated per preceding years in the background series \u2014 in Brazil, unlike in developed countries, public spending normally exceeds private. \u201cThe truth is that unfortunately, Brazilian corporations have always invested little in research and development, and this situation remains unchanged,\u201d says Soraya Smaili, ex-Dean of the Federal University of S\u00e3o Paulo and coordinator of Instituto Sou Ci\u00eancia (\u201cI am Science Institute\u201d), a center for science and higher-education studies.<\/p>\n Background series analysis enables certain transformations to be observed. Smaili draws attention to a change in the profile of human resources qualified by postgraduate programs: the increase in the number of PhDs was uneven across different knowledge areas. In engineering, the contingent of awarded PhDs more than doubled between 2000 and 2021 from close to 800 to 2,000 per year. This progress, however, was behind that of areas such as the health or human sciences. \u201cThe total number of engineers is a relevant indicator for the development of any country, and Brazil\u2019s difficulties in this area deserve further analysis,\u201d says Smaili.<\/p>\n The Science, Technology, and Innovation Indicators provide a comprehensive diagnosis of performance among public institutions and companies, and professionals engaged in research activities in the country. One of the sizeable difficulties in compiling the last survey was the lack of some primary data, which was not produced or collated, but essential for providing updated statistics.<\/p>\n The most serious example is related to the PINTEC, which the IBGE used to release every three years as a reference to demonstrate the efforts of innovative Brazilian companies. The last PINTEC was published in 2020 with data from between 2015 and 2017; no company data has been compiled since then. \u201cPINTEC is paramount to understanding the dynamics of corporate investment in R&D, and its discontinuation presents a challenge to our technicians,\u201d explains Mariana Moura of MCTI.<\/p>\n Moura states that in the absence of updated data, the solution is to run extrapolations based on older references. \u201cThe IBGE suggestion was to gather information on companies that used mechanisms to incentivize innovation, such as the IT Law (Lei de Inform\u00e1tica<\/em>) and the Lei do Bem,<\/em> a set of tax incentives for R&D to boost innovation and use it to recalculate corporate R&D investments based on data from the last available PINTEC. The issue is that, as time passes, this basis point becomes less representative,\u201d she explains.<\/p>\n![](\"\/wp-content\/uploads\/2023\/09\/RPF-Indicadores-2023-06-info2-site-1140.png\")
\n <\/picture>Alexandre Affonso \/ Revista Pesquisa FAPESP<\/span>\n![](\"\/wp-content\/uploads\/2023\/09\/RPF-Indicadores-info3-site-1140.png\")
\n <\/picture>Alexandre Affonso \/ Revista Pesquisa FAPESP<\/span>\n![](\"\/wp-content\/uploads\/2023\/09\/RPF-Indicadores-info4-site-1140.png\")
\n <\/picture>Alexandre Affonso \/ Revista Pesquisa FAPESP<\/span>\n![](\"\/wp-content\/uploads\/2023\/09\/RPF-Indicadores-info5-site-1140.png\")
\n <\/picture>Alexandre Affonso \/ Revista Pesquisa FAPESP<\/span>\n![](\"\/wp-content\/uploads\/2023\/10\/RPF-Indicadores-info6-novo-1140.jpg\")
\n <\/picture>